Negative rating slashes 10% from Intuitive Surgical | Wall Street Beat

Thu, 12/20/2012 - 5:01pm
Mass Device

A highly negative research report from Citron spooks investors into shaving 11% from Intuitive Surgical shares in 2 days. Wall Street Beat

A research report blasting Intuitive Surgical (NSDQ:ISRG) spooked investors on Wall Street yesterday and today, prompting a selloff that's shaved some 11% from the medical device company's share price.

Citron Research, citing several factors that investors had ignored, said yesterday that it expects ISRG shares to drop to $350 over the next year and as low as $250 over the next 18 months.

ISRG shares began yesterday at $547.33 each, but as The Street digested the Citron report unusually heavy trading plunged the stock to a $515.45 close, down 5.7% on the day. Shares opened today at $508.82 and slipped another 5.3% to close at $488.31 apiece.


Share this Story

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.